Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rainmed MedicalHKSE:02297 +1.36%50 Days Payable is 42.38 as of Dec. 2025, which is 15% above its 10-year median of 36.82. GuruFocus rates HKSE:02297 with a GF Score™ of 50/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Rainmed Medical ranks worse than 80.98% on this metric.
The historical rank and industry rank for Rainmed Medical's Days Payable or its related term are showing as below:
HKSE:02297'
s Days Payable Range Over the Past 10 Years
Min: 18.42 Med: 36.82 Max: 119.46
Current: 33.7
During the past 6 years, Rainmed Medical's highest Days Payable was 119.46. The lowest was 18.42. And the median was 36.82.
HKSE:02297's Days Payable is ranked worse than 80.98% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs HKSE:02297: 33.70
Rainmed Medical's Days Payable
increased
from Dec. 2024 (25.04) to Dec. 2025 (42.38).
It may suggest that Rainmed Medicaldelayed paying its suppliers.
Rainmed Medical Days Payable Related Terms
Rainmed Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Rainmed Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02297 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Rainmed Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainmed Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Rainmed Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Rainmed Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rainmed Medical (HKSE:02297) has a Days Payable of 42.38 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rainmed Medical and its competitors. This is 15% above median its historical median of 36.82. Over the past decade, Rainmed Medical's Days Payable has ranged from 18.42 to 119.46. According to the industry distribution chart, Rainmed Medical ranks #643 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 81%.
Is Rainmed Medical's Days Payable too high?
Rainmed Medical's current Days Payable of 42.38 is 15% above median its 10-year median of 36.82. Over the past 10 years, this metric has ranged from a low of 18.42 to a high of 119.46. The Medical Devices & Instruments industry median Days Payable is 67.85. Rainmed Medical's value of 42.38 is 37.5% below this industry median. Based on the distribution chart, Rainmed Medical ranks #643 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rainmed Medical has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rainmed Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rainmed Medical ranks #643 out of 794 companies for Days Payable. This places Rainmed Medical in the lower half of its industry. The industry median Days Payable is 67.85. Rainmed Medical's value of 42.38 is 37.5% below this benchmark. Historically, Rainmed Medical's own Days Payable has ranged from 18.42 to 119.46 over the past decade. While the company's 10-year median is 36.82 vs. the industry median of 67.85, Rainmed Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rainmed Medical's current Days Payable of 42.38 is 37.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rainmed Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainmed Medical's current Days Payable is 42.38, which is 15% above median its own 10-year median of 36.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainmed Medical stock overvalued right now?
Based on GuruFocus' analysis, Rainmed Medical (HKSE:02297) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.22 — trading 178.8% above its estimated fair value. The current Days Payable is 42.38, which is 15% above median its 10-year median of 36.82 and 37.5% below the Medical Devices & Instruments industry median of 67.85. Rainmed Medical's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Rainmed Medical (HKSE:02297), the current Days Payable is 42.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainmed Medical (HKSE:02297) Overvalued in 2026?
Based on GuruFocus' analysis, Rainmed Medical stock appears to be overvalued.
The current stock price of HK$0.22 is trading 178.8% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Rainmed Medical to be Significantly Overvalued.
Key valuation signals for HKSE:02297:
Days Payable: 42.38 (15% above median its 10-year median of 36.82)
GF Value™: HK$0.08 vs. price of HK$0.22 (178.8% above fair value)
Industry Position: 37.5% below the Medical Devices & Instruments median (#643 of 794)
No single metric tells the full story. See the HKSE:02297 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
50GF Score
Get the complete analysis for HKSE:02297
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02297 has been successfully added to your 
